Virginia Retirement Systems Et Al Adverum Biotechnologies, Inc. Transaction History

Virginia Retirement Systems Et Al

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$1.74 - $2.4 $74,472 - $102,720	-42,800 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$2.08 - $3.6 $16,640 - $28,800	8,000 Added 22.99%	42,800 $93,000
Q2 2021 Aug 13, 2021	BUY	$3.36 - $10.56 $116,928 - $367,488	34,800 New	34,800 $122,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.